Avoiding perioperative dexamethasone may improve the outcome of patients with rectal cancer.

[1]  D. Sessler,et al.  Is Dexamethasone Associated with Recurrence of Ovarian Cancer? , 2014, Anesthesia and analgesia.

[2]  Raj Kumar,et al.  Activation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells. , 2013, Cancer letters.

[3]  G. Saydam,et al.  Effects of dexamethasone and pheniramine hydrogen maleate on stress response in patients undergoing elective laparoscopic cholecystectomy. , 2013, American journal of surgery.

[4]  R. McCarthy,et al.  Dexamethasone to Prevent Postoperative Nausea and Vomiting: An Updated Meta-Analysis of Randomized Controlled Trials , 2013, Anesthesia and analgesia.

[5]  D J Buggy,et al.  Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis? , 2012, British journal of anaesthesia.

[6]  I. Jeremias,et al.  Glucocorticoids augment survival and proliferation of tumor cells. , 2012, Anticancer research.

[7]  D. Buggy,et al.  Can anaesthetic technique effect postoperative outcome? , 2012, Current opinion in anaesthesiology.

[8]  Minshan Chen,et al.  The Effects of Anesthetic Technique on Cancer Recurrence in Percutaneous Radiofrequency Ablation of Small Hepatocellular Carcinoma , 2012, Anesthesia and analgesia.

[9]  G. Calin,et al.  Circulating microRNAs as noninvasive biomarkers in breast cancer. , 2012, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[10]  J. Eddy,et al.  Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. , 2012, Cellular immunology.

[11]  R. Marcus,et al.  Dose ranging study on the effect of preoperative dexamethasone on postoperative quality of recovery and opioid consumption after ambulatory gynaecological surgery. , 2011, British journal of anaesthesia.

[12]  M. Büchler,et al.  Glucocorticoid-mediated apoptosis resistance of solid tumors. , 2009, Results and problems in cell differentiation.

[13]  Bruce D Keith,et al.  Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy , 2008, BMC Cancer.

[14]  Naphtali Abudarham,et al.  Amelioration of Operation-Induced Suppression of Marginating Pulmonary NK Activity using Poly IC: A Potential Approach to Reduce Postoperative Metastasis , 2007, Annals of Surgical Oncology.

[15]  C. Bauguess,et al.  The pharmacokinetics of single high doses of dexamethasone in cancer patients , 2006, European Journal of Clinical Pharmacology.

[16]  O. Frankfurt,et al.  Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates , 2004, Current opinion in oncology.

[17]  G. Shakhar,et al.  Potential Prophylactic Measures Against Postoperative Immunosuppression: Could They Reduce Recurrence Rates in Oncological Patients? , 2003, Annals of Surgical Oncology.

[18]  W. Jusko,et al.  Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia , 2003, Cancer Chemotherapy and Pharmacology.

[19]  B. Wasylyk,et al.  The p53 tumour suppressor inhibits glucocorticoid‐induced proliferation of erythroid progenitors , 2002, EMBO Reports.

[20]  V. Cristofalo,et al.  Enhanced proliferation of human fibroblasts, in the presence of dexamethasone, is accompanied by changes in p21Waf1/Cip1/Sdi1 and the insulin‐like growth factor type 1 receptor , 1998, Journal of cellular physiology.

[21]  R. Schleimer,et al.  Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. , 1996, The Journal of allergy and clinical immunology.

[22]  T. Antakly,et al.  AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. , 1995, The American journal of pathology.

[23]  W. van Putten,et al.  Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors , 1994, Neurology.

[24]  M. Yeager,et al.  Perioperative immunomodulation in cancer surgery. , 1994, American journal of surgery.

[25]  M. Brown,et al.  Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. , 1993, Cellular immunology.

[26]  J. Jeekel,et al.  Blood transfusions and prognosis in colorectal cancer. , 1993, The New England journal of medicine.

[27]  T. Donovan,et al.  Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. , 1993, Developmental pharmacology and therapeutics.

[28]  J. C. Stoof,et al.  Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone , 1992, Journal of neuroscience research.

[29]  M. Aapro.  Corticosteroids as antiemetics. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  R. Freshney.  Effects of glucocorticoids on glioma cells in culture. Minireview on cancer research. , 1984, Experimental cell biology.

[31]  A. Lowenfels,et al.  BLOOD TRANSFUSIONS AND RECURRENCE RATES IN COLONIC MALIGNANCY , 1982, The Lancet.

[32]  D. Crowther,et al.  Intermittent high‐dose cyclophosphamide with and without prednisolone. A study of the relationships between toxicity, response and survival in metastatic lung cancer , 1982, Cancer.

[33]  J. Lundy.  Anesthesia and Surgery: A Double‐Edged Sword for the Cancer Patient , 1980, Journal of surgical oncology.

[34]  V. Beral.  CARDIOVASCULAR-DISEASE MORTALITY TRENDS AND ORAL-CONTRACEPTIVE USE IN YOUNG WOMEN , 1976, The Lancet.

[35]  R. Danneel,et al.  Fortschritte der Krebsforschung , 1951 .